Published in Acta Oncol on January 01, 1994
Severe Acute Radiodermatitis in a Keloid Patient with Takayasu's Arteritis. Plast Reconstr Surg Glob Open (2015) 0.75
Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy. Neurology (1994) 2.12
High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results. Int J Radiat Oncol Biol Phys (1996) 1.44
Clinical use of a concomitant boost technique using a gypsum compensator. Int J Radiat Oncol Biol Phys (1994) 1.39
Review of methods used to study oxygen transport at the microcirculatory level. Int J Cancer (2000) 1.27
Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys (1993) 1.08
Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys (2000) 1.08
Prostate seed implant quality assessment using MR and CT image fusion. Int J Radiat Oncol Biol Phys (1999) 1.06
Comparison of two head and neck immobilization systems. Int J Radiat Oncol Biol Phys (1997) 1.04
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med (1996) 1.02
Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br J Cancer Suppl (1996) 0.96
Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker. J Surg Oncol (1997) 0.93
Tumor temperature distributions predict hyperthermia effect. Int J Radiat Oncol Biol Phys (1989) 0.93
Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg (1993) 0.91
Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperthermia (2003) 0.90
Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys (2000) 0.89
MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. Radiology (1994) 0.89
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. Int J Radiat Oncol Biol Phys (1999) 0.89
Primary tumors of the heart: a review with emphasis on diagnosis and potential treatment modalities. Semin Surg Oncol (1985) 0.87
Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. Head Neck (1994) 0.87
Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change. AJNR Am J Neuroradiol (2013) 0.85
Clinical experience with a multi-element ultrasonic hyperthermia system: analysis of treatment temperatures. Int J Hyperthermia (1991) 0.85
A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. Int J Hyperthermia (2001) 0.84
Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone. Int J Radiat Oncol Biol Phys (2001) 0.82
The role of amifostine as a radioprotector. Oncology (Williston Park) (2001) 0.81
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (1994) 0.80
The effect of head and neck radiation therapy on voice quality. Laryngoscope (1992) 0.79
Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers. Head Neck (1999) 0.79
Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring. Work in progress. Radiology (1990) 0.79
The use of hydralazine to manipulate tumour temperatures during hyperthermia. Int J Hyperthermia (1991) 0.78
Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas. J Surg Oncol (1994) 0.78
Emergency prebiopsy radiation for mediastinal masses: impact on subsequent pathologic diagnosis and outcome. J Clin Oncol (1986) 0.77
Phase I/II study of external radio frequency phased array hyperthermia and external beam radiotherapy in the treatment of prostate cancer: technique and results of intraprostatic temperature measurements. Int J Radiat Oncol Biol Phys (1992) 0.77
Artificial neural network model of survival in patients treated with irradiation with and without concurrent chemotherapy for advanced carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (1998) 0.77
Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy. Int J Radiat Oncol Biol Phys (1994) 0.76
Has the outlook improved for amifostine as a clinical radioprotector. Radiother Oncol (2001) 0.75
Where there's smoke, is there fire? Int J Hyperthermia (1999) 0.75
Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer. Semin Oncol (1997) 0.75
Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves. Technol Cancer Res Treat (2012) 0.75
Arytenoid sparing during irradiation of early stage vocal cord cancer. Int J Radiat Oncol Biol Phys (1995) 0.75
Carboplatin, etoposide, and radiotherapy, followed by surgery, for the treatment of marginally resectable non-small cell lung cancer. Cancer Treat Rev (1993) 0.75
Daily paclitaxel and thoracic radiation therapy for non-small cell lung cancer: preliminary results. Semin Radiat Oncol (1999) 0.75
Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone. Int J Radiat Oncol Biol Phys (1997) 0.75
The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine. Int J Radiat Oncol Biol Phys (1992) 0.75